Forbius is a clinical-stage biopharmaceutical company focused on developing therapies for cancer and fibrotic diseases
Forbius is a clinical-stage biopharmaceutical company focused on developing therapies for cancer and fibrotic diseases. It applies biological understanding and protein engineering to design inhibitors of the TGF-β and EGFR pathways, targeting serious illnesses.